Covenant Partners, LLC Novartis Ag Transaction History

Covenant Partners, LLC

  • $324 Million
  • Q2 2024

A detailed history of Covenant Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Covenant Partners, LLC holds 7,542 shares of NVS stock, worth $859,410. This represents 0.25% of its overall portfolio holdings.

Number of Shares
7,542
Previous 7,542 -0.0%
Holding current value
$859,410
Previous $729,000 10.01%
% of portfolio
0.25%
Previous 0.22%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024
SELL
$95.27 - $108.47 $29,247 - $33,300
-307 Reduced 3.91%
7,542 $729,000
Q4 2023

Feb 20, 2024
SELL
$92.27 - $101.54 $8,304 - $9,138
-90 Reduced 1.13%
7,849 $792,000
Q3 2023

Oct 20, 2023
SELL
$94.73 - $105.13 $3,410 - $3,784
-36 Reduced 0.45%
7,939 $808,000
Q2 2023

Aug 11, 2023
BUY
$92.52 - $104.91 $11,657 - $13,218
126 Added 1.61%
7,975 $804,000
Q1 2023

Apr 19, 2023
SELL
$80.03 - $92.81 $64,104 - $74,340
-801 Reduced 9.26%
7,849 $722,000
Q4 2022

Feb 17, 2023
SELL
$75.55 - $92.52 $136,669 - $167,368
-1,809 Reduced 17.3%
8,650 $784,000
Q2 2022

Jul 27, 2022
SELL
$80.52 - $93.75 $249,773 - $290,812
-3,102 Reduced 22.87%
10,459 $884,000
Q1 2022

May 16, 2022
BUY
$80.11 - $90.62 $196,670 - $222,472
2,455 Added 22.11%
13,561 $1.19 Million
Q4 2021

Feb 15, 2022
SELL
$79.7 - $88.13 $295,607 - $326,874
-3,709 Reduced 25.04%
11,106 $971,000
Q3 2021

Nov 12, 2021
BUY
$81.78 - $95.14 $303,322 - $352,874
3,709 Added 33.4%
14,815 $1.21 Million
Q2 2021

Aug 02, 2021
SELL
$85.24 - $94.15 $279,757 - $309,000
-3,282 Reduced 22.81%
11,106 $1.01 Million
Q1 2021

May 11, 2021
SELL
$83.5 - $98.47 $389,861 - $459,756
-4,669 Reduced 24.5%
14,388 $1.23 Million
Q4 2020

Feb 10, 2021
BUY
$78.07 - $94.43 $706,923 - $855,063
9,055 Added 90.53%
19,057 $1.8 Million
Q3 2020

Nov 10, 2020
BUY
$82.14 - $91.0 $75,404 - $83,538
918 Added 10.11%
10,002 $870,000
Q2 2020

Aug 17, 2020
SELL
$80.93 - $91.1 $121,152 - $136,376
-1,497 Reduced 14.15%
9,084 $793,000
Q1 2020

May 15, 2020
BUY
$70.67 - $99.01 $273,492 - $383,168
3,870 Added 57.67%
10,581 $872,000
Q4 2019

Feb 14, 2020
SELL
$84.35 - $95.37 $443,343 - $501,264
-5,256 Reduced 43.92%
6,711 $635,000
Q3 2019

Nov 14, 2019
BUY
$85.54 - $94.26 $449,598 - $495,430
5,256 Added 78.32%
11,967 $1.04 Million
Q2 2019

Aug 15, 2019
SELL
$75.4 - $92.8 $90,630 - $111,545
-1,202 Reduced 15.19%
6,711 $613,000
Q1 2019

May 16, 2019
BUY
$75.32 - $86.15 $138,588 - $158,516
1,840 Added 30.3%
7,913 $761,000
Q4 2018

Feb 14, 2019
BUY
$73.66 - $82.02 $447,337 - $498,107
6,073 New
6,073 $521,000

Others Institutions Holding NVS

# of Institutions
1,426
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $245B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Covenant Partners, LLC Portfolio

Follow Covenant Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covenant Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Covenant Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email